drugset / Trial / NCT02960126

Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk

NCT02960126

Phase 3 Unknown 1500 enrolled Chuncheon Sacred Heart Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study was designed in order to evaluate and compare the efficacy and safety between aspirin and clopidogrel in the patient with low stroke risk Atrial Fibrillation (AF).

Timeline

Start
2016-11
Primary completion
2020-10
Completion
2021-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 100 mg
Comparator Clopidogrel Small molecule 75 mg

Indications